Cargando…

Zoledronic acid prevents decreases in bone mineral density in patients with prostate cancer undergoing combined androgen blockade

The aim of this study was to evaluate the effect of zoledronic acid (ZA) on bone mineral density (BMD) in patients with prostate cancer receiving combined androgen blockade (CAB) as a first-line androgen deprivation therapy. Patients receiving CAB for prostate cancer without bone metastasis were can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishizawa, Satoshi, Inagaki, Takeshi, Iba, Akinori, Kikkawa, Kazuro, Kodama, Yoshiki, Matsumura, Nagahide, Kohjimoto, Yasuo, Hara, Isao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197198/ https://www.ncbi.nlm.nih.gov/pubmed/25332886 http://dx.doi.org/10.1186/2193-1801-3-586

Ejemplares similares

Prognostic factors and risk stratification in patients with castration-resistant prostate cancer receiving docetaxel-based chemotherapy
por: Yamashita, Shimpei, et al.
Publicado: (2016)

Necrotizing fasciitis after high-dose rate brachytherapy and external beam radiation for prostate cancer: a case report
por: Yamashita, Shimpei, et al.
Publicado: (2017)

Transplantation of Horseshoe Kidney from Living, Genetically Unrelated Donor
por: Kikkawa, Kazuro, et al.
Publicado: (2015)

Usefulness of Preoperative High Systemic Immune-Inflammation Index as a Prognostic Biomarker in Patients Who Undergo Radical Cystectomy for Bladder Cancer: Multicenter Analysis
por: Yamashita, Shimpei, et al.
Publicado: (2021)

Myosteatosis as a novel prognostic biomarker after radical cystectomy for bladder cancer
por: Yamashita, Shimpei, et al.
Publicado: (2020)

Enzalutamide Versus Abiraterone as a First-Line Endocrine Therapy for Castration-Resistant Prostate Cancer: Protocol for a Multicenter Randomized Phase 3 Trial
por: Hara, Isao, et al.
Publicado: (2018)

Noncontrast Computed Tomography Parameters for Predicting Shock Wave Lithotripsy Outcome in Upper Urinary Tract Stone Cases
por: Yamashita, Shimpei, et al.
Publicado: (2018)

Bladder neck size and its association with urinary continence after robot‐assisted radical prostatectomy
por: Kohjimoto, Yasuo, et al.
Publicado: (2022)

The Importance of Follow-Up and Evaluation of Intraoperative Findings to Determine Surgical Indications for Retractile Testis
por: Kikkawa, Kazuro, et al.
Publicado: (2023)

Prognostic Impact of Lymphatic Invasion in Patients with High-Risk Prostate Cancer after Robot-Assisted Radical Prostatectomy and Extended Lymph Node Dissection: A Single-Institution Prospective Cohort Study
por: Yamashita, Shimpei, et al.
Publicado: (2022)

Undifferentiated pleomorphic sarcoma of the prostate in a young man
por: Iwahashi, Yuya, et al.
Publicado: (2020)

Upper urinary tract stone disease in patients with poor performance status: active stone removal or conservative management?
por: Yamashita, Shimpei, et al.
Publicado: (2017)

Adrenocortical carcinoma with inferior vena cava tumor thrombus found during surgery
por: Nabeshima, Yuta, et al.
Publicado: (2022)

Disseminated carcinomatosis of the bone marrow caused by prostate cancer diagnosed with only bone marrow biopsy
por: Wakamiya, Takahito, et al.
Publicado: (2021)

Complete Androgen Insensitivity and Decreased Bone Mineral Density
por: Bauer, Elizabeth M, et al.
Publicado: (2021)

Essential roles of oncostatin M receptor β signaling in renal crystal formation in mice
por: Yamashita, Shimpei, et al.
Publicado: (2020)

Efficacy of zoledronic acid in older prostate cancer patients undergoing androgen deprivation therapy
por: Kojima, Ippei, et al.
Publicado: (2019)

Zoledronic acid combined with androgen-deprivation therapy may prolong time to castration-resistant prostate cancer in hormone-naïve metastatic prostate cancer patients – A propensity scoring approach
por: Nagao, Kazuhiro, et al.
Publicado: (2016)

Dynamic Changes in Fluid Temperatures during Laser Irradiation Using Various Laser Modes: A Thermography-Based In Vitro Phantom Study
por: Yamashita, Shimpei, et al.
Publicado: (2023)

Maximal androgen blockade for advanced prostate cancer
por: Mukha, Rajiv Paul, et al.
Publicado: (2010)

Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
por: Fujimoto, Naohiro, et al.
Publicado: (2011)

Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture
por: Magaziner, Jay S, et al.
Publicado: (2014)

Prior administration of vitamin K(2) improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid-induced inhibition of osteoblasts proliferation and mineralization
por: Zhao, Bin, et al.
Publicado: (2018)

PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model
por: Li, Yuan, et al.
Publicado: (2018)

Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer
por: Tamada, Satoshi, et al.
Publicado: (2018)

Role of maximum androgen blockade in advanced prostate cancer
por: Ayyathurai, Rajinikanth, et al.
Publicado: (2009)

Relationship between Decreased Mineral Intake Due to Oral Frailty and Bone Mineral Density: Findings from Shika Study
por: Suzuki, Fumihiko, et al.
Publicado: (2021)

Denosumab versus zoledronate for the treatment of low bone mineral density in male HIV-infected patients
por: Makras, Polyzois, et al.
Publicado: (2021)

The influence of zoledronate and teriparatide on gamma delta T cells in mice
por: Yamachika, Eiki, et al.
Publicado: (2017)

Suppression of the Hypothalamic-pituitary-adrenal Axis by Maximum Androgen Blockade in a Patient with Prostate Cancer
por: Kondo, Takeshi, et al.
Publicado: (2016)

Topical zoledronic acid decreases micromotion induced bone resorption in a sheep arthroplasty model
por: Jakobsen, Thomas, et al.
Publicado: (2017)

Clinicopathological and Molecular Characteristics of Macroscopically Yellowish-Colored Chromophobe Renal Cell Carcinoma Compared to Non-Yellowish-Colored Chromophobe Renal Cell Carcinoma
por: Kojima, Fumiyoshi, et al.
Publicado: (2021)

Effect of Zoledronic Acid on Bone Mineral Density in Men with Prostate Cancer Receiving Gonadotropin-Releasing Hormone Analog
por: Kapoor, Anoop, et al.
Publicado: (2011)

Effect of zoledronic acid on bone mineral density in patients of celiac disease: A prospective, randomized, pilot study
por: Kumar, Mukul, et al.
Publicado: (2013)

Ossification and increased bone mineral density with zoledronic acid in a patient with lung adenocarcinoma: A case report
por: KURISHIMA, KOICHI, et al.
Publicado: (2014)

Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine
por: Fujimura, Tetsuya, et al.
Publicado: (2018)

Predicting castration-resistant prostate cancer after combined androgen blockade
por: He, Miao, et al.
Publicado: (2017)

Radiodensitometric study for evaluation of bone mineral density around dental implants after zoledronic acid treatment in ovariectomized rats
por: Dikicier, Sibel, et al.
Publicado: (2017)

Comparison of Denosumab and Zoledronic Acid in Postmenopausal Women With Osteoporosis: Bone Mineral Density (BMD) and Trabecular Bone Score (TBS)
por: Kang, Taewook, et al.
Publicado: (2022)

Effect of Zoledronic Acid on the Vertebral Body Bone Mineral Density After Instrumented Intervertebral Fusion in Postmenopausal Women With Osteoporosis
por: Fan, Junjun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2qkr6qn2tnfa75jac0dmpkb93q